Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $36.79 USD
Change Today +0.77 / 2.14%
Volume 392.4K
RLYP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

relypsa inc (RLYP) Snapshot

Open
$36.11
Previous Close
$36.02
Day High
$37.21
Day Low
$35.79
52 Week High
03/5/15 - $42.26
52 Week Low
10/15/14 - $17.60
Market Cap
1.5B
Average Volume 10 Days
391.3K
EPS TTM
$-2.66
Shares Outstanding
41.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RELYPSA INC (RLYP)

Related News

No related news articles were found.

relypsa inc (RLYP) Related Businessweek News

No Related Businessweek News Found

relypsa inc (RLYP) Details

Relypsa, Inc., a biopharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States. Its lead product candidate includes Patiromer, a non-absorbed potassium binding polymer that completed Phase III clinical trial for the treatment of hyperkalemia. The company was founded in 2007 and is based in Redwood City, California.

145 Employees
Last Reported Date: 05/7/15
Founded in 2007

relypsa inc (RLYP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $540.1K
Founder
Total Annual Compensation: $172.5K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $321.9K
Senior Vice President of Pharmaceutical Devel...
Total Annual Compensation: $304.0K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $170.8K
Compensation as of Fiscal Year 2014.

relypsa inc (RLYP) Key Developments

Relypsa, Inc. Names Charlotte Arnold as Vice President, Corporate Communications

Relypsa, Inc. announced the appointment of Charlotte Arnold to the position of Vice President, Corporate Communications. Ms. Arnold joins Relypsa from Genentech, where she worked since 2006. Most recently, she led the corporate and cross-portfolio communications team, covering a wide breadth responsibilities including policy issues, managed care, distribution and access, as well as supporting corporate branding.

Relypsa, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Relypsa, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, net loss was $29,665,000 or $0.78 per basic and diluted share compared to $16,068,000 or $0.54 per basic and diluted share a year ago. Loss from operations was $29,267,000 against $15,704,000 a year ago.

Relypsa, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-12-2015 12:00 PM

Relypsa, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-12-2015 12:00 PM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: John A. Orwin, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RLYP:US $36.79 USD +0.77

RLYP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RLYP.
View Industry Companies
 

Industry Analysis

RLYP

Industry Average

Valuation RLYP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RELYPSA INC, please visit www.relypsa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.